Menstrual cycle irregularities can have many different causes. For some women, use of birth control pills can help regulate menstrual cycles. However, some menstrual irregularities can't be prevented. Regular pelvic exams can help ensure that problems affecting your reproductive organs are diagnosed as soon as possible.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
Menstrual cycle irregularities can have many different causes. For some women, use of birth control pills can help regulate menstrual cycles. However, some menstrual irregularities can't be prevented. Regular pelvic exams can help ensure that problems affecting your reproductive organs are diagnosed as soon as possible.
This topic contains detailed description regarding Normal puerperium, it's definition, duration, phases, involution of uterus and other pelvic organs, lochia, general physiological changes of puerperium, lactation, management of normal puerperium, management of ailments and postnatal care.
Please find the power point on Management of Preterm labor. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Many women experience some minor disorders during pregnancy.
Every system of the body may be affected during pregnancy. These disorders, however , are not minor to the pregnant woman.
Hydatidiform Mole (HM) is a rare mass or growth that forms inside the uterus at the beginning of a pregnancy. It is a type of gestational trophoblastic disease (GTD).
When a normal sperm cell fertilizes one of these oocytes, the resulting embryo has only one set of chromosomes. Because the embryo has no genes from the mother, the pregnancy cannot develop normally, resulting in a hydatidiform mole.
Please find the power point on Management of Preterm labor. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Many women experience some minor disorders during pregnancy.
Every system of the body may be affected during pregnancy. These disorders, however , are not minor to the pregnant woman.
Hydatidiform Mole (HM) is a rare mass or growth that forms inside the uterus at the beginning of a pregnancy. It is a type of gestational trophoblastic disease (GTD).
When a normal sperm cell fertilizes one of these oocytes, the resulting embryo has only one set of chromosomes. Because the embryo has no genes from the mother, the pregnancy cannot develop normally, resulting in a hydatidiform mole.
Obstetric fistula is an abnormal opening between the reproductive tract (usually the vagina) and the urinary tract (frequently the bladder) or alimentary tract (usually the rectum) or both. Obstetric fistula typically develops after several days of prolonged or obstructed labour.
HIRSCHSPRUNG DISEASE of neonate wrr.pptxShambelNegese
disease is a condition that affects the large intestine (colon) and causes problems with passing stool. The condition is present at birth (congenital) as a result of missing nerve cells in the muscles of the baby's colon.
Physiological Process that occur in a woman who has given birth up to 6wks postpartum, abnormal processes and their risk factors, clinical assessment and management
Lastly a brief review of anatomy of the breast
Similar to Postpartum bladder dysfunction& urinary retention (20)
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. Introduction
• Voiding difficulty and urinary retention is a
common phenomenon in the immediate
postpartum period.
• The importance of prompt diagnosis and
appropriate management of this condition is
the key to ensuring a rapid return to normal
bladder function.
3. Definition
• Postpartum voiding dysfunction—if defined as
failure to pass urine spontaneously within 6 hours
of vaginal delivery or catheter removal after
delivery—occurs in 0.7–4% of deliveries.
• Postpartum urinary retention is the inability to
void, with a painful (usually), palpable or
percussable bladder and the need for
catheterisation to obtain relief
4. Definition…
• Persistent postpartum urinary retention may be
defined as the inability to void spontaneously despite
the use of an indwelling catheter for three days.
• Overt retention refers to the inability to void
spontaneously within 6 hours of vaginal birth or
removal of indwelling catheter.
• Covert retention refers to increased post void
residual volumes of > 150 ml and no symptoms of
urinary retention.
5. • The postpartum bladder has a tendency to be underactive
and is, therefore, vulnerable to the retention of urine
following trauma to the bladder, pelvic floor muscles and
nerves during delivery.
• If postpartum voiding dysfunction is unrecognised, it can
lead to bladder underactivity and prolonged voiding
dysfunction, with sequelae such as recurrent UTI and
incontinence
6. • The RCOG Study Group report on incontinence
recommends that no woman should be allowed to go
longer than 6 hours, without voiding or catheterisation
postpartum.
8. Risk factors
• Primiparity
• Instrumental delivery
• Epidural, spinal or pudendal block in labour
• Prolonged second stage of labour
• Catheterisation during or after birth
9. Risk factors…
• Perineal trauma, vaginal or vulval hematomas,
edema
• History of voiding difficulties
• First vaginal birth
• Birth weight > 3.8 kg
• Caesaren section
10. Pathophysiology of urinary
retention
• One of the most common cause is the use of
regional anaesthesia due to afferent neural
blockade which supresses the sensory stimuli from
the bladder to the pontine micturition centre.
• As a result, the reflex mechanism that induces
micturition is blocked which may result in reduced
contractility of bladder and urinary retention
11. Pathophysiology…
• Result of nerve injury during delivery: The
pudendal nerve, with afferent nerve branches (S2-
4) supplying the bladder, is damaged during pelvic
surgery and vaginal delivery. There is a significant
increase in pudendal nerve terminal motor
latencies, which may take a few months to recover
post delivery
12. Pathophysiology…
• Pelvic floor tissue stretching during delivery
resulting in pudendal nerve damage: Both
instrumental delivery and prolonged labour can be
predisposing factors to this damage.
• Tissue oedema around the urogenital area,
resulting in a transient mechanical obstruction to
urine outflow.
13. Physiological changes contributing to
PPUR
Elevated progestogen levels in pregnancy and the immediate postpanum period
Reduced smooth muscle tone
Dilated bladder, ureters and renal pelvises during pregnancy and the first few
weeks post-partum.
Coupled with changes in vesical pressures (an initial rise in pregnancy followed
by a rapid drop to normal values within a few days after delivery)
Results in a hypotonic bladder in the early puerperium.
14. Clinical presentation
• Comp1ete or inability to void, to the asymptomatic patient with
large post void residual volumes.
• Clinical suspicion:
– Small voided volumes,
– urinary frequency,
– slow or intermittent stream,
– urgency,
– bladder pain or discomfort,
– urinary incontinence and those who strain to void, or
describe no sensation to void.
15. Management
• Intrapartum bladder management: Women
should be encouraged to void every 2-3 hours in
labour with a low threshold for catheterisation if
unable to void (unable to void on 2 occasions or a
palpable bladder.
• Women who have epidural analgesia: Offered
indwelling catheter for a minimum of 6 hours
postpartum or until full sensation has returned.
16. Management…
Postpartum management:
• No patient should be left >6 h without voiding or being
catheterised for residual volumes.
• Strict input and output chart should be instituted.
• Timing of voids should be recorded, and voided volumes
and post void residual volumes should be measured.
• Timed voiding every 3-4 h in the immediate postpartum
period.
17. Measures to aid voiding
• Ensure patient is well analgesed.
• Ice to perineum to help reduce oedema.
• Help the patient to stand and walk to the toilet.
• Provide privacy.
• Assist patient into a warm bath.
• Prevent constipation.
18. Management…
• Following the diagnosis of urinary retention, a
urine sample should be sent for culture. If UTI is
suspected, prompt antibiotic treatment is required.
• Place a catheter if swollen pr painful perineum
until the swelling and pain have settled.
• Avoid constipation
19. Management…
• Provide adequate analgesia as perineal pain is a
significant factor in the development of retention.
• Record the voided volume and postvoid residual
volume after removal of catheter.
• Further retention or increased residual volume
requires continued baldder emptying.
20. Management…
• Clean intermittent self catheterisation can be
taught, or if the perineum is still tender, an
indwelling catheter can be sited up to 2 weeks.
• Voiding dysfunciton after this period requires
careful assessment, including a neurological
examination.
22. Complications
• Urinary tract infection
• Urinary / faecal incontinence
• Short and long term bladder dysfunction
• Ureteric reflux
• Bilateral hydronephrosis
• Acute renal failure
• Long-term renal impairment
23. Reference
• Kearney R, Cutner A. Postpartum voiding dysfunction. The
Obstetrician & Gynaecologist 2008;10:71-74
• Postpartum bladder dysfunction. South Asian Perinatal Practice
guidelines. Department of Health. Government of South
Australia. 2012
• Lim J.L. Postpartum Voiding Dysfunction and urianry retention.
Australian and New Zealand Journal of Obstetrics and
Gynaecology 2010; 50: 502-505
• Postpartum Bladder Care: Background, practice and
complications. 2011 Retrieved form
http://www.ogpnews.com/2011/12/post-partum-bladder-care-
background-practice-and-complications/444